Roxithromycin Ambroxol Tablet Franchise in Ahmedabad

Name: Roxyfoli AM Tablet | Roxithromycin + Ambroxol | Respiratory Care Tablet
Brand: Roxyfoli AM Tablet
Rating: 4.8 (150 reviews)

Respiratory Care Tablet Supplier in Mumbai

Roxithromycin Ambroxol Tablet Distributor in Delhi

Antibiotic-Expectorant Tablet Franchise Opportunity in Bangalore

Roxithromycin Ambroxol Tablet Stockist in Hyderabad

Respiratory Care Tablet Export & Manufacturing in Chandigarh

Home/Products /roxithromycin-150mg-ambroxol-60mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Roxithromycin Ambroxol tablet exporters and suppliers

Roxithromycin Ambroxol tablet for respiratory infections

Roxithromycin 150mg + Ambroxol 60mg Tablet – PCD Pharma Franchise Marketing Material

Roxithromycin Ambroxol tablet literature PDF

Roxyfoli AM Tablet

Composition : Roxithromycin (150mg) + Ambroxol (60mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Contact For Business Query

Roxyfoli AM Tablet contains Roxithromycin 150mg + Ambroxol 60mg, a combination therapy designed to treat respiratory bacterial infections while improving mucus clearance. It helps relieve cough, congestion, and infection symptoms efficiently.

Roxithromycin acts as a macrolide antibiotic, inhibiting bacterial protein synthesis, while Ambroxol works as a mucolytic agent, thinning and clearing bronchial secretions for easier breathing.

Tablet formulation ensures accurate dosing, improved patient adherence, and rapid symptom relief. Its dual-action mechanism makes it a high-demand product in hospitals, clinics, and respiratory care pharmacies.

Adding Roxyfoli AM Tablet to your anti-infective and respiratory care portfolio strengthens your offerings with a clinically trusted, fast-moving therapy. Its prescriber acceptance, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

About the Product

Roxithromycin acts as a macrolide antibiotic, inhibiting bacterial protein synthesis, while Ambroxol works as a mucolytic agent, thinning and clearing bronchial secretions for easier breathing.

Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, or mild headache. Rare but serious side effects include allergic reactions, liver enzyme abnormalities, or severe gastrointestinal disturbances. Patients should seek immediate medical attention if severe or persistent symptoms occur.

Roxyfoli AM Tablet is indicated for the treatment of bacterial respiratory tract infections such as bronchitis, pneumonia, sinusitis, and other conditions associated with excessive mucus production, as prescribed by a healthcare professional.

Roxyfoli AM Tablet should be taken exactly as prescribed, preferably on an empty stomach for optimal antibiotic absorption. Complete the full course of therapy to prevent bacterial resistance. Inform the doctor about any history of liver or kidney disease, heart conditions, or allergies to macrolide antibiotics.

Store Roxyfoli AM Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.